Cannabinoid conditioned reward and aversion

Behavioral and neural processes

Jennifer E. Murray, Rick A Bevins

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

The discovery that delta-9-tetrahydrocannabinol (Î9-THC) is the primary psychoactive ingredient in marijuana prompted research that helped elucidate the endogenous cannabinoid system of the brain. Î9-THC and other cannabinoid ligands with agonist action (CP 55,940, HU210, and WIN 55,212-2) increase firing of dopamine neurons and increase synaptic dopamine in brain regions associated with reward and drug addiction. Such changes in cellular processes have prompted investigators to examine the conditioned rewarding effects of the cannabinoid ligands using the place conditioning task with rats and mice. As reviewed here, these cannabinoid ligands can condition place preferences (evidence for rewarding effects) and place aversions (evidence for aversive qualities). Notably, the procedural details used in these place conditioning studies have varied across laboratories. Such variation includes differences in apparatus type, existence of procedural biases, dose, number of conditioning trials, injection-to- placement intervals, and pretraining drug exposure. Some differences in outcome across studies can be explained by these procedural variables. For example, low doses of Î9-THC appear to have conditioned rewarding effects, whereas higher doses have aversive effects that either mask these rewarding effects or condition a place aversion. Throughout this review, we highlight key areas that need further research.

Original languageEnglish (US)
Pages (from-to)265-278
Number of pages14
JournalACS Chemical Neuroscience
Volume1
Issue number4
DOIs
StatePublished - Apr 21 2010

Fingerprint

Cannabinoids
Reward
Dronabinol
Ligands
Dopamine
Brain
Dopaminergic Neurons
Cannabis
Masks
Research
Pharmaceutical Preparations
Neurons
Substance-Related Disorders
Rats
Research Personnel
Outcome Assessment (Health Care)
Injections
Conditioning (Psychology)

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Cannabinoid conditioned reward and aversion : Behavioral and neural processes. / Murray, Jennifer E.; Bevins, Rick A.

In: ACS Chemical Neuroscience, Vol. 1, No. 4, 21.04.2010, p. 265-278.

Research output: Contribution to journalReview article

@article{9ef22d359d1b42b691e8642148b7cbf3,
title = "Cannabinoid conditioned reward and aversion: Behavioral and neural processes",
abstract = "The discovery that delta-9-tetrahydrocannabinol ({\^I}9-THC) is the primary psychoactive ingredient in marijuana prompted research that helped elucidate the endogenous cannabinoid system of the brain. {\^I}9-THC and other cannabinoid ligands with agonist action (CP 55,940, HU210, and WIN 55,212-2) increase firing of dopamine neurons and increase synaptic dopamine in brain regions associated with reward and drug addiction. Such changes in cellular processes have prompted investigators to examine the conditioned rewarding effects of the cannabinoid ligands using the place conditioning task with rats and mice. As reviewed here, these cannabinoid ligands can condition place preferences (evidence for rewarding effects) and place aversions (evidence for aversive qualities). Notably, the procedural details used in these place conditioning studies have varied across laboratories. Such variation includes differences in apparatus type, existence of procedural biases, dose, number of conditioning trials, injection-to- placement intervals, and pretraining drug exposure. Some differences in outcome across studies can be explained by these procedural variables. For example, low doses of {\^I}9-THC appear to have conditioned rewarding effects, whereas higher doses have aversive effects that either mask these rewarding effects or condition a place aversion. Throughout this review, we highlight key areas that need further research.",
author = "Murray, {Jennifer E.} and Bevins, {Rick A}",
year = "2010",
month = "4",
day = "21",
doi = "10.1021/cn100005p",
language = "English (US)",
volume = "1",
pages = "265--278",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Cannabinoid conditioned reward and aversion

T2 - Behavioral and neural processes

AU - Murray, Jennifer E.

AU - Bevins, Rick A

PY - 2010/4/21

Y1 - 2010/4/21

N2 - The discovery that delta-9-tetrahydrocannabinol (Î9-THC) is the primary psychoactive ingredient in marijuana prompted research that helped elucidate the endogenous cannabinoid system of the brain. Î9-THC and other cannabinoid ligands with agonist action (CP 55,940, HU210, and WIN 55,212-2) increase firing of dopamine neurons and increase synaptic dopamine in brain regions associated with reward and drug addiction. Such changes in cellular processes have prompted investigators to examine the conditioned rewarding effects of the cannabinoid ligands using the place conditioning task with rats and mice. As reviewed here, these cannabinoid ligands can condition place preferences (evidence for rewarding effects) and place aversions (evidence for aversive qualities). Notably, the procedural details used in these place conditioning studies have varied across laboratories. Such variation includes differences in apparatus type, existence of procedural biases, dose, number of conditioning trials, injection-to- placement intervals, and pretraining drug exposure. Some differences in outcome across studies can be explained by these procedural variables. For example, low doses of Î9-THC appear to have conditioned rewarding effects, whereas higher doses have aversive effects that either mask these rewarding effects or condition a place aversion. Throughout this review, we highlight key areas that need further research.

AB - The discovery that delta-9-tetrahydrocannabinol (Î9-THC) is the primary psychoactive ingredient in marijuana prompted research that helped elucidate the endogenous cannabinoid system of the brain. Î9-THC and other cannabinoid ligands with agonist action (CP 55,940, HU210, and WIN 55,212-2) increase firing of dopamine neurons and increase synaptic dopamine in brain regions associated with reward and drug addiction. Such changes in cellular processes have prompted investigators to examine the conditioned rewarding effects of the cannabinoid ligands using the place conditioning task with rats and mice. As reviewed here, these cannabinoid ligands can condition place preferences (evidence for rewarding effects) and place aversions (evidence for aversive qualities). Notably, the procedural details used in these place conditioning studies have varied across laboratories. Such variation includes differences in apparatus type, existence of procedural biases, dose, number of conditioning trials, injection-to- placement intervals, and pretraining drug exposure. Some differences in outcome across studies can be explained by these procedural variables. For example, low doses of Î9-THC appear to have conditioned rewarding effects, whereas higher doses have aversive effects that either mask these rewarding effects or condition a place aversion. Throughout this review, we highlight key areas that need further research.

UR - http://www.scopus.com/inward/record.url?scp=77951689566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951689566&partnerID=8YFLogxK

U2 - 10.1021/cn100005p

DO - 10.1021/cn100005p

M3 - Review article

VL - 1

SP - 265

EP - 278

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 4

ER -